10-Q · May 14, 2026
Healthcare Triangle, Inc. (HCTI) reported significantly improved financials in Q4 2025 with revenues of $9.86 million, marking a 166% increase compared to $3.70 million in the same quarter of the previous year. However,…
Earnings analysis · 10-Q
Filed August 13, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q extract is limited to market-risk, controls, legal-proceeding, and other-information sections and does not include current-quarter revenue, margins, EPS, balance-sheet data, cash flow, or segment…
The supplied 10-Q extract is limited to market-risk, controls, legal-proceeding, and other-information sections and does not include current-quarter revenue, margins, EPS, balance-sheet data, cash flow, or segment results. Controls were deemed effective as of June 30, 2026, and management reported no material control changes or unusual litigation. No material risk-factor changes or quantitative financial guidance were disclosed.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, under the supervision of the COO and CFO.
The company reported no changes during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect internal control over financial reporting.
The filing states that the company is not currently involved in any claim outside the ordinary course that is material to financial condition or results of operations.
Item 1A states that there were no material changes to the risk factors disclosed in the Form 10-K filed April 16, 2026; therefore, the filing provides no new quantified risk-factor exposure.
Under Item 3, the company states that it had no investments and did not use derivative financial instruments to manage interest-rate risk, limiting disclosure of any related market-risk exposure.
The filing does not provide the current-quarter financial statements, balance-sheet amounts, cash-flow figures, or segment results in the supplied text, preventing assessment of liquidity and operating trends for the quarter ended June 30, 2026.
The provided 10-Q text contains no quantitative revenue or EPS outlook and does not state whether prior guidance was raised, maintained, lowered, or withdrawn.
Healthcare Triangle, Inc. (HCTI) reported significantly improved financials in Q4 2025 with revenues of $9.86 million, marking a 166% increase compared to $3.70 million in the same quarter of the previous year. However,…
Healthcare Triangle (HCTI) positions itself as a cloud- and data-focused healthcare IT vendor with proprietary platforms (CloudEz, DataEz, Readabl.AI, Ziloy, Ezovion) and partnerships with AWS, Google Cloud and…
Healthcare Triangle reported Q3 2025 revenue of $3,489,000, up from $2,413,000 in Q3 2024, but the company widened operating loss and reported a net loss of $1,906,000 (EPS -$0.42). Liquidity improved via equity…
Healthcare Triangle positions itself as a healthcare IT and cloud/data science services provider emphasizing proprietary platforms CloudEz, DataEz and Readabl.AI (all “commercially available”) and partnerships with AWS,…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.